This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ozawa, Y. Articles by Saruta, T. Search for Related Content PubMed PubMed Citation Articles by Ozawa, Y. Articles by Saruta, T. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB PHENTOLAMINE Related Collections Ion channels/membrane transport Other Vascular biology

(Hypertension. 2001;38:343.)
© 2001 American Heart Association, Inc.

Scientific Contributions

Effect of T-Type Selective Calcium Antagonist on Renal Microcirculation

Studies in the Isolated Perfused Hydronephrotic Kidney

Yuri Ozawa; Koichi Hayashi; Takahiko Nagahama; Keiji Fujiwara; Takao Saruta

Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.

Correspondence to Takao Saruta, MD, Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160, Japan. E-mail saruta{at}mc.med.keio.ac.jp

Abstract—— Although calcium antagonists exert preferential vasodilation of renal afferent arterioles, we have recently demonstrated that nilvadipine and efonidipine, possessing both L-type and T-type calcium channel blocking action, reverse the angiotensin (Ang) II–induced afferent and efferent arteriolar constriction. In the present study, we investigated the role of T-type calcium channels in mediating the Ang II–induced efferent arteriolar tone using the selective T-type calcium channel blocker mibefradil. Isolated perfused hydronephrotic rat kidneys were used for direct visualization of renal microcirculation. Administration of Ang II (0.3 nmol/L) caused marked constriction of afferent (from 13.5±0.6 to 9.2±0.6 µm, P<0.01, n=6) and efferent (from 11.5±1.0 to 7.4±0.7 µm, P<0.01, n=5) arterioles. Mibefradil (1 µmol/L) dilated both vessels, with 82±11% and 72±7% reversal of afferent and efferent arterioles, respectively. Similarly, nickel chloride (100 µmol/L) caused dilation of both arterioles, similar in magnitude in afferent (68±10%, n=7) and efferent (80±7%, n=7) arterioles. To eliminate the possibility that the mibefradil-induced dilation was mediated by L-type channel blockade, mibefradil was administered in the presence of nifedipine (1 µmol/L). Thus, nifedipine caused modest efferent arteriolar dilation (30±6% reversal, n=9), and subsequent addition of mibefradil elicited further dilation of this vessel (80±4%, P<0.01 versus nifedipine). Furthermore, mibefradil reversed the Ang II–induced efferent arteriolar constriction even in the presence of nifedipine and phentolamine. These findings demonstrate that T-type calcium antagonists markedly dilate the Ang II–induced efferent arteriolar constriction, but the action is not mediated by inhibition of catecholamine release. This potent activity would contribute to the efferent arteriolar response to nilvadipine and efonidipine and may offer benefit in light of glomerular hemodynamics.

Key Words: mibefradil • afferent arteriole • efferent arteriole • T-type calcium channel • calcium antagonists • renal microcirculation

This article has been cited by other articles:

				T. C. Major, S. Dhamija, N. Black, S. Liachenko, B. Morenko, G. Sobocinski, C. Okerberg, P. Tinholt, S. Madore, and M. C. Kowala The T- and L-Type Calcium Channel Blocker (CCB) Mibefradil Attenuates Leg Edema Induced by the L-Type CCB Nifedipine in the Spontaneously Hypertensive Rat: A Novel Differentiating Assay J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 723 - 731. [Abstract] [Full Text] [PDF]

				K. Hayashi, S. Wakino, N. Sugano, Y. Ozawa, K. Homma, and T. Saruta Ca2+ Channel Subtypes and Pharmacology in the Kidney Circ. Res., February 16, 2007; 100(3): 342 - 353. [Abstract] [Full Text] [PDF]

				M.-G. Feng and L. G. Navar Nitric oxide synthase inhibition activates L- and T-type Ca2+ channels in afferent and efferent arterioles Am J Physiol Renal Physiol, April 1, 2006; 290(4): F873 - F879. [Abstract] [Full Text] [PDF]

				M.-G. Feng, M. Li, and L. G. Navar T-type calcium channels in the regulation of afferent and efferent arterioles in rats Am J Physiol Renal Physiol, February 1, 2004; 286(2): F331 - F337. [Abstract] [Full Text] [PDF]

				E. Perez-Reyes Molecular Physiology of Low-Voltage-Activated T-type Calcium Channels Physiol Rev, January 1, 2003; 83(1): 117 - 161. [Abstract] [Full Text] [PDF]